Category
Earnings & Investor News press releases
267 releases
T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND
T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), a global asset management firm and a leader in retirement, announced today that its Board of Directors…
Black Hills Corp. Reports 2026 Third-Quarter Results and Reaffirms 2026 Earnings Guidance
Reaffirms 2026 adjusted earnings guidance in the range of $4.25 to $4.45 per share, excluding merger-related costs
Manulife Reports Third Quarter 2026 Results
Manulife Financial Corporation ("Manulife" or the "Company") reported its third quarter results for the period ended September 30, 2026, delivering…
Chiron Real Estate Inc. Announces Third Quarter 2026 Financial Results
Sunlife Reports Third Quarter 2026 Results
Sunlife's(1) Q3 results reflect growth across Canada, Asia, U.S. stop loss, and GreenOak, with double-digit growth in underlying EPS. TORONTO, Nov.…
Koppers Holdings Inc. Declares Quarterly Cash Dividend
Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals, and carbon compounds, today…
Cognex Reports Third Quarter 2026 Results
Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the third quarter…
Progyny, Inc. Announces Third Quarter 2026 Results
Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net Income
CrossAmerica Partners LP Reports Third Quarter 2026 Results
Reported Third Quarter of 2026 Net Income of $8.8 million, Adjusted EBITDA of $38.7 million and Distributable Cash Flow of $21.8 million compared to…
Magnite Reports Third Quarter 2026 Results
Contribution ex-TAC(1) Grows 20% Year-Over-Year
CARRIAGE SERVICES INC
Carriage Services Announces Third Quarter 2026 Results, Updates 2026 Guidance
Excelerate Energy, Inc.
Excelerate Energy Reports Strong Third Quarter 2026 Results
Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Received Regenerative Medicine Advanced Therapy (RMAT) Designation from U.S. FDA for TN-401 Gene Therapy for PKP2-Associated Arrhythmogenic Right…
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
3Q 2026 Total Revenue of $141.1 Million, Increasing 5% Year-over-Year
Dutch Bros Inc. Reports Third Quarter 2026 Financial Results
Achieves 30% Revenue Growth Year-Over-Year